The All Wales Medicines Strategy Group started the assessment of ivacaftor (Kalydeco) as soon as the drug company formally engaged with the appraisal process. This process is recognised to be robust and normally takes about 21 weeks to allow all parties, including patient organisations such as the Cystic Fibrosis Trust, to submit their comments. The final appraisal decision for Kalydeco is scheduled to be reached at a public meeting on 8th May 2013.
More top news
New captain Alun Wyn Jones in England icons Martin Johnson and Lawrence Dallaglio's class, says coach Sean Edwards.
A grandfather from Barry will be the first person in the UK to have surgery on live TV when his colonoscopy is broadcast later.
A rather mild, generally dry but cloudy for many of us. The odd spot of light rain or drizzle is possible, mainly over the hills.